Veracity Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,397
Closed -$211K 215
2023
Q2
$211K Buy
+2,397
New +$206K 0.09% 202
2022
Q4
Sell
-2,597
Closed -$210K 196
2022
Q3
$210K Sell
2,597
-4
-0.2% -$359 0.11% 166
2022
Q2
$233K Sell
2,601
-239
-8% -$24.2K 0.12% 166
2022
Q1
$315K Sell
2,840
-3
-0.1% -$317 0.13% 164
2021
Q4
$294K Buy
2,843
+14
+0.5% +$1.62K 0.12% 186
2021
Q3
$355K Buy
2,829
+181
+7% +$23.4K 0.15% 153
2021
Q2
$329K Buy
2,648
+33
+1% +$4.14K 0.08% 189
2021
Q1
$309K Sell
2,615
-373
-12% -$43.7K 0.14% 168
2020
Q4
$350K Sell
2,988
-424
-12% -$46.7K 0.18% 144
2020
Q3
$355K Sell
3,412
-4,194
-55% -$421K 0.2% 124
2020
Q2
$697K Sell
7,606
-14,954
-66% -$1.43M 0.4% 74
2020
Q1
$2.03M Buy
22,560
+2,169
+11% +$231K 0.59% 37
2019
Q4
$2.31M Buy
+20,391
New +$2.24M 0.6% 35

Other funds holding MDT

Veracity Capital's MDT Position: Q3 2023 in Review

Veracity Capital sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,397 shares — an estimated $211K sold.

Veracity Capital first reported a position in MDT in Q4 2019 and held it in 13 quarters. The position peaked at $2.31M in Q4 2019. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Veracity Capital reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Veracity Capital sold 2,397 Medtronic shares in Q3 2023, an estimated $211K.
  • Veracity Capital first reported a position in Medtronic in Q4 2019 and held it in 13 quarters.
  • Veracity Capital's Medtronic position peaked at $2.31M in Q4 2019.
  • 1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Veracity Capital's 13F filing for Q3 2023, filed 25 Oct 2023.